 Home > Medical News > Medicines Company News > OptraSCAN announces the launch of CytoSiA

OptraSCAN announces the launch of CytoSiA

 Last Update: 2021-07-06
 Source: Internet
 Author: User

Tags

digital print solutions

blunt filter glass

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

OptraSCAN®, the world's leading provider of on-demand digital pathology solutions, today announced the launch of its smart solution CytoSiA, which can quickly and economically scan and analyze liquid-based cytology sections and Pap smears
.

This is a comprehensive solution consisting of OptraSCAN digital pathology scanner, storage and powerful artificial intelligence (AI) algorithms, which can assist pathologists and cytology technologists in screening and detecting cervical cancer, precancerous lesions, and SARS Type cells and all other cytological categories

"OptraSCAN founder Abhi Gholap said, "OptraSCAN redefines cervical cancer screening by launching CytoSiA
.

CytoSiA can provide a large number of features to effectively screen liquid-based cytology slices and Pap smears, so that the Bethesda classification method can be used to distinguish between normal and abnormal squamous cell carcinoma (NILM/LSIL/HSIL/SCC) Cervical cells

The OptraSCANS digital scanner can scan a 15x15 mm cytology section at 40x magnification in 60 seconds while producing the highest quality images
.

CytoSia uses a patented technology-composite imaging, which can find all the focus pixels from various Z-plane images and re-splice them to form a single-layer composite image

When CytoSiA is used as a companion diagnostic tool, if the pathologist’s interpretation is found to be inconsistent with the results of the AI algorithm, it will notify the pathologist to prevent errors or misinterpretations and improve the overall quality of care
.

CytoSiA features:

Automatically calculate the sample adequacy of the entire slice cytology image
Use Bethesda score to identify abnormal cells and other entities based on morphological features and AI classification
Identify reactive, endometrium, actinomycetes, candida, clue cells, Trichomonas vaginalis and herpes entities
Identify entities such as blood, inflammation, and lubricants

Dr.
Aparna Joshi, Medical Director of OptraSCAN, said, “AI-based image analysis requires the use of high-quality images
.

” “Our team has developed an intelligent imaging technology that can convert physical glass cytology slices into clear digital Image

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.